Atrion Corporation (NASDAQ:ATRI) will begin trading ex-dividend on September 14, 2020. The quarterly dividend payment of $ 1.75 per share is scheduled to be paid on September 30, 2020. The dividend yield based on the latest trading day closing price was 1.10 %. Owners of shares, purchased before the ex-dividend date will be eligible for the dividend.
Dividends History
wpDataTable with provided ID not found!Click Here For More Historical Dividends Of Atrion Corporation
Atrion Corporation recently reported second quarter financial results on August 6, 2020, after market close, the Allen based company reported income for the second quarter of $ 4.68 per share, from the revenue of $ 37.97 million. The quarterly earnings elevated 58.33 percent while revenues compared with the same quarter last year.
According to street consensus, revenue of was expected for the second quarter The bottom line results street analysts by $ 0.02 or , at the same time, top line results analysts by $ 6 million or .
Stock Performance
Shares of Atrion Corporation traded low $ -3.10 or -0.48 percent on Thursday, reaching $ 637.70 with volume of 2.80 thousand shares. Atrion Corporation has traded high as $ 638.91 and has cracked $ 636.01 on the downward trend
According to the previous trading day, closing price of $ 637.70, representing a 10.67 % increase from the 52 week low of $ 579.00 and a 24.27 % decrease over the 52 week high of $ 846.15.
The company has a market capital of $ 1.17 billion and is part of the Healthcare sector and Medical Instruments & Supplies industry.
Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The companys cardiovascular products comprise MPS2 Myocardial Protection System that delivers fluids and medications, mixes critical drugs, and controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery.
